VYNE Therapeutics
VYNE
$1.56
Share price
-3.70%
Change (1 day)
-43.48%
Change (1 year)
Categories
EPS for VYNE Therapeutics (VYNE)
EPS in 2023 (TTM): -$11.04
According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$11.04. In 2022 the company made an earnings per share (EPS) of -$7.33 an increase over its 2021 EPS that were of -$25.92.
EPS history for VYNE Therapeutics from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$11.04 | 50.61% |
| 2022 | -$7.33 | -71.72% |
| 2021 | -$25.92 | -84.19% |
| 2020 | -$163.98 | -26.29% |
| 2019 | -$222.48 | 28.75% |
| 2018 | -$172.80 | 10.79% |
| 2017 | -$155.97 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$2.18 | -80.25% | 🇺🇸 USA |